Cargando…

Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience

Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score...

Descripción completa

Detalles Bibliográficos
Autores principales: Mudalagiri, Manasa, Ayyar, Vageesh, Bantwal, Ganapathi, George, Belinda, Appaiah, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067793/
http://dx.doi.org/10.4103/2230-8210.342224
_version_ 1784700085674704896
author Mudalagiri, Manasa
Ayyar, Vageesh
Bantwal, Ganapathi
George, Belinda
Appaiah, Sonali
author_facet Mudalagiri, Manasa
Ayyar, Vageesh
Bantwal, Ganapathi
George, Belinda
Appaiah, Sonali
author_sort Mudalagiri, Manasa
collection PubMed
description Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score retrospectively and determine its usefulness in the management of our PA patients. Results: Sixteen patients were included in the study (56.3% males) with mean age of 34.25 years. Presenting feature was headache in 87.5%, visual disturbance in 50%, seizures in 18.8% and focal deficit in 6.3%. The precipitating event was found in 3 (18.9%). The mean PAS in conservatively managed patients was 0.27 and in those surgically managed was 3.2. Emergent pituitary surgery was performed in 5 patients (31.3%) of which 4 had PAS of >3. Conclusion: Clinical severity based on PAS ≥ 3 appeared to influence the management towards emergency surgical intervention and can be a useful tool to monitor conservatively managed patients and intervene.
format Online
Article
Text
id pubmed-9067793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90677932022-05-05 Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience Mudalagiri, Manasa Ayyar, Vageesh Bantwal, Ganapathi George, Belinda Appaiah, Sonali Indian J Endocrinol Metab Abstracts … Esicon 2021 Introduction: Pituitary apoplexy score (PAS) is a clinical tool, scored from 0 to10, consisting of GCS, visual acuity, visual field defects and ocular muscle function. It helps assess the clinical severity and outcome of patients with pituitary apoplexy (PA). Aims and Objectives: To apply PAS score retrospectively and determine its usefulness in the management of our PA patients. Results: Sixteen patients were included in the study (56.3% males) with mean age of 34.25 years. Presenting feature was headache in 87.5%, visual disturbance in 50%, seizures in 18.8% and focal deficit in 6.3%. The precipitating event was found in 3 (18.9%). The mean PAS in conservatively managed patients was 0.27 and in those surgically managed was 3.2. Emergent pituitary surgery was performed in 5 patients (31.3%) of which 4 had PAS of >3. Conclusion: Clinical severity based on PAS ≥ 3 appeared to influence the management towards emergency surgical intervention and can be a useful tool to monitor conservatively managed patients and intervene. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067793/ http://dx.doi.org/10.4103/2230-8210.342224 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Abstracts … Esicon 2021
Mudalagiri, Manasa
Ayyar, Vageesh
Bantwal, Ganapathi
George, Belinda
Appaiah, Sonali
Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
title Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
title_full Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
title_fullStr Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
title_full_unstemmed Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
title_short Abstract 103: The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience
title_sort abstract 103: the pituitary apoplexy score (pas) in the evaluation and management of pituitary apoplexy: a single centre experience
topic Abstracts … Esicon 2021
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067793/
http://dx.doi.org/10.4103/2230-8210.342224
work_keys_str_mv AT mudalagirimanasa abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience
AT ayyarvageesh abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience
AT bantwalganapathi abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience
AT georgebelinda abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience
AT appaiahsonali abstract103thepituitaryapoplexyscorepasintheevaluationandmanagementofpituitaryapoplexyasinglecentreexperience